We are live on ! Find out more
NVAX icon

Novavax
NVAX

155 hedge funds and large institutions have $218M invested in Novavax in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 66 increasing their positions, 31 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 31

29% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 17

3% more funds holding

Funds holding: 151 → 155 (+4)

0.13% less ownership

Funds ownership: 2.26% → 2.13% (-0.13%)

8% less call options, than puts

Call options by funds: $2.08M | Put options by funds: $2.27M

33% less capital invested

Capital invested by funds: $327M → $218M (-$109M)

Holders
155
Holders Change
+4
Holders Change %
+2.65%
% of All Funds
3.55%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
66
Reduced
31
Closed
17
Calls
$2.08M
Puts
$2.27M
Net Calls
-$189K
Net Calls Change
-$950K

Top Buyers

1
BlackRock
BlackRock
New York
+$9.66M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$8.4M
3
Morgan Stanley
Morgan Stanley
New York
+$6.08M
4
CH
CVI Holdings
Delaware
+$5.6M
5
Two Sigma Investments
Two Sigma Investments
New York
+$2.67M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$12.2M
2
Deutsche Bank
Deutsche Bank
Germany
-$7.58M
3
Millennium Management
Millennium Management
New York
-$6.13M
4
JP Morgan Chase
JP Morgan Chase
New York
-$4.26M
5
BBA
Baker Bros. Advisors
New York
-$4.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$41.3M +$9.66M +285,837 +23%
State Street
2
State Street
Massachusetts
$31.2M -$3.25M -96,194 -8%
Vanguard Group
3
Vanguard Group
Pennsylvania
$28.2M +$8.4M +248,412 +31%
BB
4
BB Biotech
Switzerland
$11.2M – – –
Morgan Stanley
5
Morgan Stanley
New York
$8.41M +$6.08M +179,833 +134%
Franklin Resources
6
Franklin Resources
California
$7.65M – – –
JP Morgan Chase
7
JP Morgan Chase
New York
$6.11M -$4.26M -125,976 -36%
Northern Trust
8
Northern Trust
Illinois
$5.93M +$1.35M +39,899 +22%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$5.84M – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$5.3M +$1.58M +46,698 +31%
CH
11
CVI Holdings
Delaware
$4.44M +$5.6M +165,780 New
RSCM
12
Rock Springs Capital Management
Maryland
$4.36M +$845K +25,000 +18%
RI
13
RTW Investments
New York
$3.54M -$139K -4,108 -3%
Ameriprise
14
Ameriprise
Minnesota
$2.88M +$3.04K +90 +0.1%
Charles Schwab
15
Charles Schwab
California
$2.88M +$1.05M +31,145 +41%
Two Sigma Investments
16
Two Sigma Investments
New York
$2.44M +$2.67M +78,869 +637%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$2.31M +$340K +10,062 +13%
Millennium Management
18
Millennium Management
New York
$2.27M -$6.13M -181,359 -68%
Wellington Management Group
19
Wellington Management Group
Massachusetts
$1.89M +$2.26M +66,901 +1,904%
Deutsche Bank
20
Deutsche Bank
Germany
$1.8M -$7.58M -224,180 -77%
Two Sigma Advisers
21
Two Sigma Advisers
New York
$1.73M +$1.46M +43,255 +203%
TWMP
22
Taylor Wealth Management Partners
Massachusetts
$1.68M +$1.17M +34,540 +122%
EAM
23
Eagle Asset Management
Florida
$1.68M +$2.11M +62,526 New
TCIM
24
TIAA CREF Investment Management
New York
$1.22M +$43.5K +1,286 +3%
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$1.18M -$322K -9,526 -18%
1
2 3 4 5

NVAX Hedge Fund Activity: Q2 2018 in Review

155 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q2 2018, worth a combined $218M — down 33% from $327M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new NVAX positions and 17 closed out — a net gain of 5 holders — while 66 added to existing stakes and 31 trimmed.

The largest buyer was BlackRock, adding an estimated $9.66M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $12.2M sold.

  • 155 institutional investors held Novavax (NVAX) as of Q2 2018, up from 151 in Q1 2018.
  • Funds reported $218M of Novavax stock for Q2 2018, down 33% quarter-over-quarter.
  • 22 funds opened new Novavax positions in Q2 2018 and 17 closed out, a net change of +5 holders.
  • The largest Novavax buyer in Q2 2018 was BlackRock, an estimated $9.66M added.
  • The largest Novavax seller in Q2 2018 was Renaissance Technologies, an estimated $12.2M sold.

Based on aggregated 13F filings for Q2 2018.